Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMODELTA: Temocillin PK/PD in Non-ICU Patients
NCT03557840Unknown
- Start
- Apr 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of temocillin in complicated urinary tract infection (cUTI), pyelonephritis, lower respiratory tract infection (LRTI) and 1 more. Primary endpoints: Pharmacokinetics of total plasma temocillin at 12 days and Pharmacokinetics of unbound plasma temocillin at 12 days. Status: unknown.
02
Drugs
temocillin
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritislower respiratory tract infection (LRTI)Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT03557840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557840.